Who Paid My Doc
Tralokinumab: Vaccine Response Time
ClinicalTrials.gov NCT03562377
Research payments
$147,757
Through program year 2021, $147,757 in research payments was reported against Tralokinumab: Vaccine Response Time, across 56 payments, paid by LEO Pharma AS.
- Paid by
- LEO Pharma AS
- ClinicalTrials.gov
- NCT03562377
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $2,640 | 1 |
| 2020 | Research | $145,117 | 55 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Manuel Sanchez Hialeah, FL Named on 6 payments
- Debra Breneman Cincinnati, OH Named on 6 payments
- Mark Amster Brighton, MA Named on 3 payments
- Richard Granstein New York, NY Named on 3 payments
- Janet Dubois Austin, TX Named on 3 payments
- Barbara Baxter Dallas, TX Named on 3 payments
- Afshin Farzadmehr Los Angeles, CA Named on 3 payments
- Megan Landis Corydon, IN Named on 2 payments
- Sandra Johnson Fort Smith, AR Named on 2 payments
- David Stoll Beverly Hills, CA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.